These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10790955)

  • 41. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use and safety profile of non-steroidal antiinflammatory drugs among Turkish patients with osteoarthritis.
    Yilmaz H; Gürel S; Ozdemir O
    Turk J Gastroenterol; 2005 Sep; 16(3):138-42. PubMed ID: 16245223
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms by which endogenous glucocorticoid protects against indomethacin-induced gastric injury in rats.
    Filaretova L; Tanaka A; Miyazawa T; Kato S; Takeuchi K
    Am J Physiol Gastrointest Liver Physiol; 2002 Nov; 283(5):G1082-9. PubMed ID: 12381521
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Stress, non-steroidal anti-inflammatory drugs, estrogens. What increases reflux symptoms?].
    Stiefelhagen P
    MMW Fortschr Med; 2009 May; 151(22):18-9. PubMed ID: 19526961
    [No Abstract]   [Full Text] [Related]  

  • 45. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs.
    Fiorucci S; Antonelli E; Distrutti E; Rizzo G; Mencarelli A; Orlandi S; Zanardo R; Renga B; Di Sante M; Morelli A; Cirino G; Wallace JL
    Gastroenterology; 2005 Oct; 129(4):1210-24. PubMed ID: 16230075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Letter by Kurth regarding article, "Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events".
    Kurth T
    Circulation; 2006 Sep; 114(11):e495; author reply e496. PubMed ID: 16966592
    [No Abstract]   [Full Text] [Related]  

  • 47. Upper gastrointestinal disorders induced by non-steroidal anti-inflammatory drugs.
    Chiba T; Sato K; Kudara N; Shinozaki H; Ikeda K; Sato K; Endo M; Orii S; Suzuki K
    Inflammopharmacology; 2008 Feb; 16(1):16-20. PubMed ID: 18256801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Serious gastrointestinal effects of nonsteroidal anti-inflammatory drugs (NSAIDS) in a prospective study in Morocco].
    Benkirane R; El Kihal L; Nabil S; Benchekroun-Belabbés A; El Feydi AE; Soulaymani R
    Sante; 2005; 15(2):113-7. PubMed ID: 16061449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of non-steroidal antiinflammatory drugs-induced gastropathy: follow up of protocol adherence.
    Aguas M; Pons M; Barrera N; Arboix A; Eguileor B; Delás J
    Rev Esp Enferm Dig; 2002 Nov; 94(11):679-86. PubMed ID: 12690991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The editor's roundtable: nonsteroidal antiinflammatory drugs and cardiovascular risk.
    Friedewald VE; Bennett JS; Packer M; Roberts WC; Williams GW
    Am J Cardiol; 2008 Oct; 102(8):1046-55. PubMed ID: 18929707
    [No Abstract]   [Full Text] [Related]  

  • 51. Gastrointestinal tract disorder as a side effect of non-steroidal anti inflammatory drugs (NSAIDs).
    Simadibrata M
    Acta Med Indones; 2004; 36(4):195-6. PubMed ID: 15931719
    [No Abstract]   [Full Text] [Related]  

  • 52. Protecting the stomach from the "toxins" of NSAIDS and anti-platelet agents.
    Echelmeyer S; Kanwal F
    Mo Med; 2009; 106(5):343-5. PubMed ID: 19902714
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Recurrence of gastropathies caused by intake of nonsteroidal anti-inflammatory drugs].
    Karameev AE
    Ter Arkh; 2003; 75(5):74-8. PubMed ID: 12847904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physicians' approaches to the use of gastroprotective strategies in low-risk non-steroidal anti-inflammatory drug users.
    Murthy SK; Kauldher S; Targownik LE
    Aliment Pharmacol Ther; 2006 May; 23(9):1365-72. PubMed ID: 16629943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [NSAID-gastropathy: state-of-the-art therapy optimization capabilities in outpatient practice].
    Burkov SG; Arutiunov AT; Gurova NIu; Lobanova EG; Nikiforov PA; Okoemov MN; Cherezova IN; Chugunnikova LI
    Eksp Klin Gastroenterol; 2008; (3):97-101. PubMed ID: 19145889
    [No Abstract]   [Full Text] [Related]  

  • 56. [Helicobacter pylori infection--current status in clinical practice and prospects].
    Malfertheiner P
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():15-9. PubMed ID: 12466998
    [No Abstract]   [Full Text] [Related]  

  • 57. Gastric effects of the novel non-steroidal anti-inflammatory drug amtolmetin guacyl.
    Coruzzi G; Bertaccini G
    Nutrition; 1999 Apr; 15(4):325-6. PubMed ID: 10319368
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment and prophylaxis of alimentary tract lesions caused by non-steroid anti-inflammatory drugs].
    Gil J; Wojtuń S
    Pol Merkur Lekarski; 2009 May; 26(155):353-7. PubMed ID: 19606672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Non steroidal anti-inflammatory drugs (NSAIDs) - balancing gastrointestinal complications and the cardiovascular risk].
    Kandulski A; Venerito M; Malfertheiner P
    Dtsch Med Wochenschr; 2009 Aug; 134(33):1635-40; quiz 1641-4. PubMed ID: 19650027
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevention of NSAID-induced gastroduodenal complications.
    Hiele M
    Clin Rheumatol; 1996 Sep; 15(5):431-4. PubMed ID: 8894354
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.